Ross King: Ledger

Stories naming Ross King. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Deputy Chair	Brandon BioCatalyst	Brandon BioCatalyst, Brandon BioCatalyst team page

Fund close $439m

Peter Beattie AC appointed Brandon BioCatalyst Chair

Brandon BioCatalyst has named Peter Beattie its chair as Bill Ferris retires, with Andrew Nash joining the board and Ross King becoming deputy; manager Brandon Capital's newly raised $439 million fund was noted.

Brandon BioCatalyst portfolio Tue 19 Aug 2025 Brandon Capital Australian Institute for Bioengineering and Nanotechnology Brandon BioCatalyst Burnet Institute Citigroup CSL Goldman Sachs Australia Institute for Molecular Bioscience University of Queensland Vicebio NRF Corporation Dr Andrew Nash Bill Ferris AC Dr Chris Nave Peter Beattie AC Ross King

Ross King

Roles

Coverage

Peter Beattie AC appointed Brandon BioCatalyst Chair